39.17
Schlusskurs vom Vortag:
$38.16
Offen:
$38.89
24-Stunden-Volumen:
936.29K
Relative Volume:
1.99
Marktkapitalisierung:
$1.94B
Einnahmen:
$3.53B
Nettoeinkommen (Verlust:
$30.99M
KGV:
63.86
EPS:
0.6134
Netto-Cashflow:
$154.99M
1W Leistung:
-1.71%
1M Leistung:
+0.49%
6M Leistung:
+68.76%
1J Leistung:
+61.46%
Astrana Health Inc Stock (ASTH) Company Profile
Firmenname
Astrana Health Inc
Sektor
Branche
Telefon
(626) 282-0288
Adresse
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ASTH
Astrana Health Inc
|
39.17 | 1.94B | 3.53B | 30.99M | 154.99M | 0.6134 |
|
HCA
Hca Healthcare Inc
|
375.17 | 83.23B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
172.57 | 14.86B | 21.46B | 2.65B | 3.35B | 19.23 |
|
DVA
Davita Inc
|
207.91 | 13.34B | 13.84B | 1.10B | 1.49B | 10.42 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.59 | 12.67B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
98.03 | 9.72B | 6.07B | 793.80M | 464.40M | 5.9914 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-12 | Eingeleitet | Needham | Buy |
| 2025-04-01 | Eingeleitet | Barclays | Equal Weight |
| 2024-10-14 | Eingeleitet | TD Cowen | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-07-11 | Hochstufung | Truist | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-26 | Eingeleitet | Jefferies | Buy |
| 2024-02-22 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-01-24 | Eingeleitet | Stifel | Buy |
| 2023-12-22 | Eingeleitet | Truist | Hold |
| 2023-10-17 | Eingeleitet | BTIG Research | Buy |
| 2023-04-12 | Eingeleitet | BofA Securities | Neutral |
| 2022-12-19 | Eingeleitet | Lake Street | Buy |
| 2022-09-21 | Eingeleitet | William Blair | Outperform |
| 2022-01-11 | Fortgesetzt | Colliers Securities | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Astrana Health Inc Aktie (ASTH) Neueste Nachrichten
Astrana Health Inc (ASTH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Astrana Health Inc (ASTH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Astrana Health Inc (ASTH) Institutional Confidence - TradingKey
Astrana Health Inc (ASTH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Astrana Health Inc (ASTH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Astrana Health Inc (ASTH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Astrana Health Inc (ASTH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Astrana Health Inc (ASTH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ASTH Stock Price, Quote & Chart - ChartMill
Is Astrana Health Inc (ASTH) a Bargain After 3.1% Drop? GF Value Says Undervalued - GuruFocus
Astrana Health (ASTH) director receives 4,525 restricted stock award - Stock Titan
Director Mazdyasni granted 4,525 Astrana Health (ASTH) restricted shares vesting in 2027 - Stock Titan
Astrana Health (ASTH) director gets 4,991 new restricted shares - Stock Titan
Astrana Health (ASTH) director Weili Dai receives 4,525-share restricted stock grant - Stock Titan
[Form 4] Astrana Health, Inc. Insider Trading Activity - Stock Titan
Astrana Health stock hits 52-week high at 39.97 USD By Investing.com - Investing.com Nigeria
Astrana Health stock hits 52-week high at 39.97 USD - Investing.com
ASTH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Astrana Health (ASTH) investors approve expanded 2024 equity incentive plan to 2036 - Stock Titan
Will First-Time Fortune 1000 Status Reshape Astrana Health's (ASTH) Value-Based Care Investment Narrative? - simplywall.st
Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth - PR Newswire
AI-driven Astrana Health hits $3.18B revenue, now a Fortune 1000 company - Stock Titan
ASTH Reiterated by BTIG -- Price Target Maintained at $50.00 - GuruFocus
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Astrana Health (ASTH) price target increased by 18.07% to 44.43 - MSN
Astrana Health, Inc. (ASTH) Misses Q3 Earnings Estimates - MSN
Astrana Health names George Christides interim medical director By Investing.com - Investing.com Nigeria
Astrana Health Raised to Overweight From Equal-Weight by Barclays - Moomoo
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack - Yahoo Finance
Astrana Health Q1 2026 slides: 56% revenue growth, full-risk shift accelerates - Investing.com Nigeria
Astrana Health closes deal with Prospect Health at a lower price - MSN
Does Astrana’s AI Partnership With California Physicians Reshape the Bull Case for Astrana Health (ASTH)? - Sahm
A Look at Astrana Health Inc (ASTH) After 3.5% Decline -- GF Val - GuruFocus
Cash-Rich Stocks: Appian and Array Face Challenges, Astrana Health ShinesNews and Statistics - IndexBox
Is Astrana’s Q1 Results and AI Platform Push Altering The Investment Case For Astrana Health (ASTH)? - Yahoo Finance
52-Week High Stocks: Sell EchoStar, Watch Vita Coco and Astrana HealthNews and Statistics - IndexBox
Astrana Health (ASTH) COO and CFO surrenders 8,155 shares for tax withholding - Stock Titan
Astrana Health partners with California physician group By Investing.com - Investing.com Nigeria
Astrana Health says Prospect deal is ahead of schedule as Q1 trends beat expectations - MSN
Astrana Health Q1 2026 Results: Revenue Beat and AI-Driven Growth - IndexBox
5 Revealing Analyst Questions From Astrana Health’s Q1 Earnings Call - Yahoo Finance
Will Strong Q1 Results and New Leadership Shift Astrana Health's (ASTH) Value-Based Care Narrative - simplywall.st
Baird Lifts PT on Astrana Health (ASTH) Following Q1 Results - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH), Bristol-Myers Squibb (BMY) and Progyny (PGNY) - The Globe and Mail
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $47 - Moomoo
Finanzdaten der Astrana Health Inc-Aktie (ASTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Astrana Health Inc-Aktie (ASTH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
| Kitayama Mitchell W | Director |
Sep 15 '25 |
Option Exercise |
18.20 |
8,000 |
145,600 |
29,060 |
| Schmidt David | Director |
Sep 02 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
35,763 |
| Chiang John | Director |
Aug 13 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
43,132 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):